Issue link: https://www.e-digitaleditions.com/i/1546950
Drug Delivery to the Lungs (DDL) 2026 will be held in person and virtually, Wednesday, December 9 to Friday, December 11, at the Edinburgh International Conference Centre in Edinburgh, UK. All lectures will be streamed live to the online audience. Inhalation OctOber 2026 9 PREVIEWING DDL2026 D rug Delivery to the Lungs (DDL) 2026 will be held in person and virtually, Wednesday, Decem- ber 9 to Friday, December 11, at the Edinburgh International Con- ference Centre in Edinburgh, UK. All lectures will be streamed live to the online audience. e confer- ence will feature invited lectures, presentations selected from sub- mitted papers, poster sessions and an extensive exhibition. e annual lecture will be pre- sented by David Cipolla, PhD, of Insmed, Inc. whose topic will be "Development challenges with inhaled formulations." Conference topics e conference session themes are: • Propellants, planet and patients: Clinical needs and advocacy • Site-specific aerosol delivery • A d v a n c e s i n s o l i d s t a t e formulation • Inhaled antimicrobials and vaccines • Digital drug delivery to the lungs (dDDL) The DDL Incubator New this year, the DDL Incuba- tor Session will explore funding options available to start-ups, bio- tech founders and similar stake- holders. e event will also feature short pitches with feedback and networking opportunities. e conference will include the Pat Burnell Young Investigator Competition, the DDL Emerg- ing Scientist Award and the New Researcher Network (NRN). Students will continue to enjoy complimentary registration. For more information and registra- tion: https://ddl-conference.com.

